First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)—a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG
Titel:
First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)—a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG
Auteur:
Lindemann, K. Christensen, R.D. Vergote, I. Stuart, G. Izquierdo, M.A. Kærn, J. Havsteen, H. Eisenhauer, E. Ridderheim, M. Lopez, A.B. Hirte, H. Aavall-Lundquvist, E. Vrdoljak, E. Green, J. Kristensen, G.B.